[Intra-portal chemoprevention and therapy of liver metastases].
Laffer
U
U
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D011169:Portal Vein; D011183:Postoperative Complications / Q000401:mortality; D011897:Random Allocation
D008937:Mitomycins; D016685:Mitomycin; D005472:Fluorouracil
Intraportale Chemoprävention und -therapie von Lebermetastasen.